Follow us on
SMS-oncology

Blog

Are you ready for the new EudraVigilance System?

Are you ready for the new EudraVigilance System?

1 November 2017, Canan Karakaya, Pharmacovigilance Manager

The new system has implications for all users of the EudraVigilance system, such as National Competent Authorities, Marketing Authorisation Holders and Sponsors of clinical trials. All users have to ensure that their processes and local...Read more

CICON2017: Translating Science into Survival #3

20 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Frankfurt, Germany), prepared by SMS-oncolog...Read more

CICON2017: Translating Science into Survival #2

CICON2017: Translating Science into Survival #2

19 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Fran...Read more

CICON2017: Translating Science into Survival #1

CICON2017: Translating Science into Survival #1

15 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Fran...Read more

The year after; was the CRA-academy really the gateway to become a great CRA?

The year after; was the CRA-academy really the gateway to become a great CRA?

22 June 2017, Alicia Veerman MSc, Clinical Research Associate

So here we are again, already more than a year later since we participated in SMS-oncology's first CRA-academy. Might sound cliché but time indeed seems to fly when you are having fun. We certainly enjoyed the past year, and more importa...Read more

Compassionate Use: providing cancer care outside trials

Compassionate Use: providing cancer care outside trials

2 May 2017, Fleur Eeman MSc, Clinical Research Associate & Jasmijn Hubers MD PhD, Medical Monitor

Being a challenging and arduous operation, finding new therapies to treat cancer often is a time-consuming process. For some patients, marketed therapies are to no avail, while at the same moment new optional therapies are on the way to...Read more

The changing landscape of oncology clinical trials - AACR 2017

The changing landscape of oncology clinical trials - AACR 2017

14 April 2017, Nadina Grosios PhD MPH, Director Consultancy

The 2017 annual meeting of the American Association for Cancer Research (AACR) could not start any better. A fascinating plenary session included Angela Belcher (Massachusetts Institute of Technology) and Bert Vogelstein (Sidney Kimmel C...Read more

EMA anticancer drug recommendations for approval in 2016

EMA anticancer drug recommendations for approval in 2016

27 January 2017, Canan Karakaya, Pharmacovigilance Manager & Nadina Grosios, Director Consultancy

Among the 81 medicines recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) in 2016, there were 13 recommendations made for novel oncology products, just slightly down from 16 in the previous year. These...Read more

ESMO 2016 - upcoming themes in oncology drug development

ESMO 2016 - upcoming themes in oncology drug development

17 October 2016, Stephan Winckels, Director Medical Affairs

If you have not visited the ESMO conference for some years, you might be astonished by the rapid growth this conference has seen. This year's attendance was well over 20,000 persons and therefore not only the largest ESMO ever, but also...Read more

SMS-oncology takes part in Ride for the Roses

SMS-oncology takes part in Ride for the Roses

9 September 2016, Lindy Bosch, Business Developer

Congratulations to "De vier Ds" team, our SMS-oncology colleagues Nadina, Philine, Fleur, Stephan, Miraj, Julia and Yuka, for taking part in the Ride for the Roses on Sunday 4th September to help raise money for cancer research, awarenes...Read more

The gateway to become a great CRA; personal CRA-academy experience

The gateway to become a great CRA; personal CRA-academy experience

20 July 2016, Fleur Eeman, Clinical Research Associate

So here we are, all five of us being part of different project teams and excited about performing our first visits as Clinical Research Associates (CRAs). Already a few months ago, we participated in SMS-oncology's first CRA-academy. Aft...Read more

"Woman v Cancer" Ride the Night

"Woman v Cancer" Ride the Night

31 May 2016, Lindy Bosch, Business Developer

We are very proud of and would like to congratulate our colleague Nadina Grosios for fundraising and taking part in the "Women v Cancer" Ride The Night 100 Km cycle challenge through London last weekend, 28th May 2016, in support of thre...Read more

CIMT 2016 - Rise of mRNA therapeutics, a relatively new class of treatment

CIMT 2016 - Rise of mRNA therapeutics, a relatively new class of treatment

24 May 2016, Julia Holland, Consultant

The increase of titles related to RNA-based therapeutics and vaccines within the CIMT poster session compared to previous years, highlighted the increased focus on RNA approaches. Therefore, some details will be given in this second CIMT...Read more

CIMT 2016 "Mechanisms of efficacy in cancer immunotherapy"

CIMT 2016 "Mechanisms of efficacy in cancer immunotherapy"

20 May 2016, Jasmijn Hubers, Medical Monitor

For 14 years now, the largest meeting in Europe focused on cancer immunotherapies, the CIMT Annual Meeting, gathers the knowledge and progress of academia, scientific organizations, industry and clinical research. It provides a comprehen...Read more

AACR 2016 - Precision medicine in paediatric cancer

AACR 2016 - Precision medicine in paediatric cancer

29 April 2016, Nadina Grosios, Director Consultancy

One of the topics that featured at length in this year's annual meeting of the American Association for Cancer Research (AACR) was paediatric oncology. Progress and challenges were discussed in aspects across the spectrum from genomics,...Read more

EMA anticancer drug approval recommendations in 2015

EMA anticancer drug approval recommendations in 2015

21 January 2016, Nadina Grosios, Director Consultancy

In 2015, the European Medicines Agency (EMA) made a total of 93 positive recommendations to the European Commission for medicines to receive marketing approval; 39 of which concerned new active substances. Approximately one third of thes...Read more

Immunotherapy - old and new personalised medicine perspectives

Immunotherapy - old and new personalised medicine perspectives

27 November 2015, Nadina Grosios, Director Consultancy

The European Society for Medical Oncology (ESMO) held its annual immune-oncology symposium in Lausanne on Friday 20th and Saturday 21st November 2015, providing a great opportunity for anyone interested to find out about all aspects of i...Read more

SMS-oncology: Q, Q, Q!

SMS-oncology: Q, Q, Q!

26 October 2015, Paul Mooney, Consultant Quality Manager

SMS-oncology's Quality Management System (QMS) is currently being overhauled to facilitate better compliance with International Conference for Harmonization - Good Clinical Practice (ICH-GCP) guidelines and with the EU "Clinical Trials D...Read more

Archive
Contact us for more information Request for proposal